{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:34:39Z","timestamp":1764333279047,"version":"3.40.5"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Helicobacter pylori and Cryptococcus ssp. are pathogenic ureolytic microorganisms that cause several\ndisorders in the host organism and, in severe cases, lead to death. Both infections have the urease enzyme\nas a key virulence factor since they use its ability to produce ammonia to soften the inhospitable pH to which\nthey are subjected. In this review, we describe two ureases as possible molecular targets for drug discovery and\nprovide insights for developing potent inhibitors against ureases from these pathogenic microorganisms through\ncomputer-aided drug discovery approaches, such as structure-based drug design (SBDD) and structure-activity\nrelationship (SAR). The SAR studies have indicated several essential subunits and groups to be present in urease\ninhibitors that are critical for inhibitory activity against H. pylori or Cryptococcus spp. Since the threedimensional\nstructure of C. neoformans urease has yet to be determined experimentally, the plant urease of\nCanavalia ensiformis was used in this study due to its structural similarity. Therefore, in the SBDD context,\nFTMap and FTSite analyses were performed to reveal characteristics of the urease active sites in two protein\ndata bank files (4H9M, Canavalia ensiformis, and 6ZJA, H. pylori). Finally, a docking-based analysis was performed\nto explore the best inhibitors described in the literature to understand the role of the ligand interactions\nwith the key residues in complex ligand-urease stabilization, which can be applied in the design of novel bioactive\ncompounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666230329122902","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T09:02:50Z","timestamp":1680166970000},"page":"777-792","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Computational Strategies Targeting Inhibition of Helicobacter pylori and\nCryptococcus neoformans Ureases"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-3046","authenticated-orcid":true,"given":"Marci\u00e9li","family":"Fabris","sequence":"first","affiliation":[{"name":"Chemistry Department, Laboratory of Synthesis of Medicinal Molecules (LaSMMed), State University of Londrina (UEL), Celso\nGarcia CID Road, Campus Universit\u00e1rio, Londrina, Paran\u00e1, 86057-970, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-419X","authenticated-orcid":true,"given":"Nailton M.","family":"Nascimento-J\u00fanior","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Organic Chemistry,\nLaboratory of Medicinal Chemistry, Organic Synthesis and Molecular Modeling (LaQMedSOMM), Institute of Chemistry, S\u00e3o\nPaulo State University (Unesp), Professor Francisco Degni Street, 55, Jardim Quitandinha, Araraquara-SP, 14800-060, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6001-360X","authenticated-orcid":true,"given":"Marcelle L.F.","family":"Bispo","sequence":"additional","affiliation":[{"name":"Chemistry Department, Laboratory of Synthesis of Medicinal Molecules (LaSMMed), State University of Londrina (UEL), Celso\nGarcia CID Road, Campus Universit\u00e1rio, Londrina, Paran\u00e1, 86057-970, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-2119","authenticated-orcid":true,"given":"Priscila G.","family":"Camargo","sequence":"additional","affiliation":[{"name":"Chemistry Department, Laboratory of Synthesis of Medicinal Molecules (LaSMMed), State University of Londrina (UEL), Celso\nGarcia CID Road, Campus Universit\u00e1rio, Londrina, Paran\u00e1, 86057-970, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"Kusters J.G.","year":"2006","unstructured":"Kusters J.G.; van Vliet A.H.M.; Kuipers E.J.; Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006,19(3),449-490","journal-title":"Clin Microbiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.gtc.2021.02.001","volume":"50","author":"Cho J.","year":"2021","unstructured":"Cho J.; Prashar A.; Jones N.L.; Moss S.F.; Helicobacter pylori Infection. Gastroenterol Clin North Am 2021,50(2),261-282","journal-title":"Gastroenterol Clin North Am"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"Hooi J.K.Y.","year":"2017","unstructured":"Hooi J.K.Y.; Lai W.Y.; Ng W.K.; Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology 2017,153(2),420-429","journal-title":"Gastroenterology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"713955","DOI":"10.3389\/fmicb.2021.713955","volume":"12","author":"Alexander S.M.","year":"2021","unstructured":"Alexander S.M.; Retnakumar R.J.; Chouhan D.; Helicobacter pylori in human stomach: The inconsistencies in clinical outcomes and the probable causes. Front Microbiol 2021,12,713955","journal-title":"Front Microbiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"Chey W.D.","year":"2017","unstructured":"Chey W.D.; Leontiadis G.I.; Howden C.W.; Moss S.F.; ACG clinical guideline: Treatment of Helicobacter pylori infection. Am J Gastroenterol 2017,112(2),212-239","journal-title":"Am J Gastroenterol"},{"key":"ref=6","first-page":"112","volume":"10","author":"Diaconu S.","year":"2017","unstructured":"Diaconu S.; Predescu A.; Moldoveanu A.; Pop C.S.; Fierbin\u021beanu-Braticevici C. Helicobacter pylori infection: old and new. J Med Life 2017,10(2),112-117","journal-title":"J Med Life"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0256225","DOI":"10.1371\/journal.pone.0256225","volume":"16","author":"Huang X.","year":"2021","unstructured":"Huang X.; Liu Y.; Lin Z.; Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China. PLoS One 2021,16(9),e0256225","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.clinthera.2005.12.012","volume":"27","author":"Fung H.B.","year":"2005","unstructured":"Fung H.B.; Doan T.L.; Tinidazole: A nitroimidazole antiprotozoal agent. Clin Ther 2005,27(12),1859-1884","journal-title":"Clin Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.idc.2021.03.012","volume":"35","author":"Gushiken A.C.","year":"2021","unstructured":"Gushiken A.C.; Saharia K.K.; Baddley J.W.; Cryptococcosis. Infect Dis Clin North Am 2021,35(2),493-514","journal-title":"Infect Dis Clin North Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","volume":"57","author":"Setianingrum F.","year":"2019","unstructured":"Setianingrum F.; Rautemaa-Richardson R.; Denning D.W.; Pulmonary cryptococcosis: A review of pathobiology and clinical aspects. Med Mycol 2019,57(2),133-150","journal-title":"Med Mycol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/21505594.2019.1614383","volume":"10","author":"Zaragoza O.","year":"2019","unstructured":"Zaragoza O.; Basic principles of the virulence of Cryptococcus. Virulence 2019,10(1),490-501","journal-title":"Virulence"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e1007144","DOI":"10.1371\/journal.ppat.1007144","volume":"14","author":"Fu M.S.","year":"2018","unstructured":"Fu M.S.; Coelho C.; De Leon-Rodriguez C.M.; Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH. PLoS Pathog 2018,14(6),e1007144","journal-title":"PLoS Pathog"},{"year":"2018","key":"ref=13","unstructured":"Guidelines on the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection; World Health Organization: Geveva, Switzerland. World Health Organization2018"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e13543","DOI":"10.1111\/ctr.13543","volume":"33","author":"Baddley J.W.","year":"2019","unstructured":"Baddley J.W.; Forrest G.N.; Cryptococcosis in solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant 2019,33(9),e13543","journal-title":"Clin Transplant"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"Perfect J.R.","year":"2010","unstructured":"Perfect J.R.; Dismukes W.E.; Dromer F.; Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010,50(3),291-322","journal-title":"Clin Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3389\/fmicb.2020.01837","volume":"11","author":"Li Y.","year":"2020","unstructured":"Li Y.; Zou M.; Yin J.; Liu Z.; Lu B.; Microbiological, epidemiological, and clinical characteristics of patients with cryptococcal meningitis at a tertiary hospital in China: A 6-year retrospective analysis. Front Microbiol 2020,11,1837","journal-title":"Front Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s40506-020-00239-0","volume":"12","author":"Moeng L.R.","year":"2020","unstructured":"Moeng L.R.; Milburn J.; Jarvis J.N.; Lawrence D.S.; HIV-associated cryptococcal meningitis: A review of novel short-course and oral therapies. Curr Treat Options Infect Dis 2020,12(4),422-437","journal-title":"Curr Treat Options Infect Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/mmy\/myx054","volume":"56","author":"Wirth F.","year":"2018","unstructured":"Wirth F.; de Azevedo M.I.; Pilla C.; Aquino V.R.; Neto G.W.; Goldani L.Z.; Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis. Med Mycol 2018,56(3),257-262","journal-title":"Med Mycol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcatb.2009.01.003","volume":"59","author":"Krajewska B.","year":"2009","unstructured":"Krajewska B.; Ureases I.; Functional, catalytic and kinetic properties: A review. J Mol Catal, B Enzym 2009,59(1-3),9-21","journal-title":"J Mol Catal, B Enzym"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.7754394","volume":"268","author":"Lippard S.J.","year":"1995","unstructured":"Lippard S.J.; At last the crystal structure of urease. Science 1995,268(5213),996-997","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0969-2126(99)80026-4","volume":"7","author":"Benini S.","year":"1999","unstructured":"Benini S.; Rypniewski W.R.; Wilson K.S.; Miletti S.; Ciurli S.; Mangani S.; A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: why urea hydrolysis costs two nickels. Structure 1999,7(2),205-216","journal-title":"Structure"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1039\/C6MD00108D","volume":"7","author":"Stumpfe D.","year":"2016","unstructured":"Stumpfe D.; Bajorath J.; Recent developments in SAR visualization. MedChemComm 2016,7(6),1045-1055","journal-title":"MedChemComm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.ailsci.2022.100039","volume":"2","author":"Yang Z.","year":"2022","unstructured":"Yang Z.; Tian Y.; Kong Y.; Zhu Y.; Yan A.; Classification of JAK1 inhibitors and SAR research by machine learning methods. Artif Intell Life Sci 2022,2,100039","journal-title":"Artif Intell Life Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.2174\/1568026619666191114123452","volume":"19","author":"Kataria R.","year":"2019","unstructured":"Kataria R.; Khatkar A.; In-silico designing, ADMET analysis, synthesis and biological evaluation of novel derivatives of diosmin against urease protein and Helicobacter pylori Bacterium. Curr Top Med Chem 2019,19(29),2658-2675","journal-title":"Curr Top Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/14756366.2019.1706503","volume":"35","author":"Li W.Y.","year":"2020","unstructured":"Li W.Y.; Ni W.W.; Ye Y.X.; N-monoarylacetothioureas as potent urease inhibitors: Synthesis, SAR, and biological evaluation. J Enzyme Inhib Med Chem 2020,35(1),404-413","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejmech.2018.06.065","volume":"156","author":"Liu Q.","year":"2018","unstructured":"Liu Q.; Shi W.K.; Ren S.Z.; Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur J Med Chem 2018,156,126-136","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.bioorg.2021.105010","volume":"114","author":"Mamidala R.","year":"2021","unstructured":"Mamidala R.; Bhimathati S.R.S.; Vema A.; Discovery of novel dihydropyrimidine and hydroxamic acid hybrids as potent Helicobacter pylori urease inhibitors. Bioorg Chem 2021,114,105010","journal-title":"Bioorg Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejmech.2013.07.047","volume":"68","author":"Xiao Z.P.","year":"2013","unstructured":"Xiao Z.P.; Peng Z.Y.; Dong J.J.; Synthesis, molecular docking and kinetic properties of \u03b2-hydroxy-\u03b2-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. Eur J Med Chem 2013,68,212-221","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bioorg.2015.12.007","volume":"64","author":"Khan A.","year":"2016","unstructured":"Khan A.; Hashim J.; Arshad N.; Dihydropyrimidine based hydrazine dihydrochloride derivatives as potent urease inhibitors. Bioorg Chem 2016,64,85-96","journal-title":"Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.bmcl.2018.08.025","volume":"28","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Su M.; Zhang X.; Liu Q.; He Z.; Xu C.; Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study. Bioorg Med Chem Lett 2018,28(19),3182-3186","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/molecules25061352","volume":"25","author":"Fan T.","year":"2020","unstructured":"Fan T.; Guo X.; Zeng Q.; Synthesis and structure-activity relationship of palmatine derivatives as a novel class of antibacterial agents against Helicobacter pylori. Molecules 2020,25(6),1352","journal-title":"Molecules"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","volume":"545","author":"Richter M.F.","year":"2017","unstructured":"Richter M.F.; Drown B.S.; Riley A.P.; Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 2017,545(7654),299-304","journal-title":"Nature"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41598-022-05736-4","volume":"12","author":"Sohrabi M.","year":"2022","unstructured":"Sohrabi M.; Nazari Montazer M.; Farid S.M.; Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents. Sci Rep 2022,12(1),2003","journal-title":"Sci Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1039\/D0RA02363A","volume":"10","author":"Imran M.","year":"2020","unstructured":"Imran M.; Waqar S.; Ogata K.; Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches. RSC Advances 2020,10(27),16061-16070","journal-title":"RSC Advances"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/1568026618666180813152921","volume":"18","author":"Wang X.","year":"2018","unstructured":"Wang X.; Song K.; Li L.; Chen L.; Structure-based drug design strategies and challenges. Curr Top Med Chem 2018,18(12),998-1006","journal-title":"Curr Top Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1107\/S2059798322002741","volume":"78","author":"Jones G.","year":"2022","unstructured":"Jones G.; Jindal A.; Ghani U.; Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Acta Crystallogr D Struct Biol 2022,78(6),690-697","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/bioinformatics\/btp036","volume":"25","author":"Brenke R.","year":"2009","unstructured":"Brenke R.; Kozakov D.; Chuang G.Y.; Fragment-based identification of druggable \u2018hot spots\u2019 of proteins using Fourier domain correlation techniques. Bioinformatics 2009,25(5),621-627","journal-title":"Bioinformatics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nprot.2015.043","volume":"10","author":"Kozakov D.","year":"2015","unstructured":"Kozakov D.; Grove L.E.; Hall D.R.; The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc 2015,10(5),733-755","journal-title":"Nat Protoc"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btr651","volume":"28","author":"Ngan C.H.","year":"2012","unstructured":"Ngan C.H.; Hall D.R.; Zerbe B.; Grove L.E.; Kozakov D.; Vajda S.; FTSite: high accuracy detection of ligand binding sites on unbound protein structures. Bioinformatics 2012,28(2),286-287","journal-title":"Bioinformatics"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.7754395","volume":"268","author":"Jabri E.","year":"1995","unstructured":"Jabri E.; Carr M.; Hausinger R.; Karplus P.; The crystal structure of urease from Klebsiella aerogenes. Science 1995,268(5213),998-1004","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jmb.2010.05.009","volume":"400","author":"Balasubramanian A.","year":"2010","unstructured":"Balasubramanian A.; Ponnuraj K.; Crystal structure of the first plant urease from jack bean: 83 years of journey from its first crystal to molecular structure. J Mol Biol 2010,400(3),274-283","journal-title":"J Mol Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41467-020-20485-6","volume":"12","author":"Cunha E.S.","year":"2021","unstructured":"Cunha E.S.; Chen X.; Sanz-Gaitero M.; Mills D.J.; Luecke H.; Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 \u00c5 resolution. Nat Commun 2021,12(1),230","journal-title":"Nat Commun"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"Jones G.","year":"1997","unstructured":"Jones G.; Willett P.; Glen R.C.; Leach A.R.; Taylor R.; Development and validation of a genetic algorithm for flexible docking. Edited by FE Cohen J Mol Biol 1997,267(3),727-748","journal-title":"Edited by FE Cohen J Mol Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/prot.20588","volume":"61","author":"Mooij W.T.M.","year":"2005","unstructured":"Mooij W.T.M.; Verdonk M.L.; General and targeted statistical potentials for protein-ligand interactions. Proteins 2005,61(2),272-287","journal-title":"Proteins"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230329122902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215125\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230329122902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T05:59:31Z","timestamp":1692251971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215125\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230329122902","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}